Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
Mass-media advertising can encourage more people experiencing stroke symptoms to go to the hospital more quickly, according to a study published in Stroke: Journal of the American Heart Association.
Almost two-thirds (65%) of hip fracture patients aged 65 and older had surgery on the day they were admitted to hospital or the next day in 2005?2006, but new indicators published by the Canadian Institute for Health Information (CIHI) show that some patients have longer waits.
Obesity is a risk factor for many serious illnesses including heart disease, type-2 diabetes, hypertension, stroke, and certain types of cancer. Child obesity is of particular concern.
When an air traffic controller at the end of a double shift forgets the location of an aircraft that had recently appeared on his screen, it may be that he did not properly take in the visual information.
The U.S. Food and Drug Administration (FDA) issued a safety alert on Avandia, diabetes drug approved to treat type 2 diabetes. I believe safety alert on Glaxo’s diabetes drug Avandia is a timely action by US FDA health agency, remarked Dr. Anil Singhal.
Researchers at the University of Warwick have found that sexual orientation has a real effect on how we perform mental tasks such as navigating with a map in a car but that old age does not discriminate on grounds of sexual orientation and withers all men?s minds alike just ahead of women?s.
A new study presented showed that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia, relative to placebo.
The results of numeracy and literacy tests for seven-year-old children can be predicted by measuring the length of their fingers, shows new research.
A new study presented showed that ramelteon did not impair middle-of-the-night balance, mobility or memory performance in older adults with insomnia, relative to placebo.